Overview

R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study has the purpose to compare R-CHOP versus R-mini-CEOP in elderly patients (>65 years) with Diffuse Large B Cell Lymphoma (DLBCL).
Phase:
Phase 3
Details
Lead Sponsor:
Fondazione Italiana Linfomi ONLUS
Treatments:
Cyclophosphamide
Doxorubicin
Epirubicin
Liposomal doxorubicin
Prednisone
Rituximab
Vinblastine
Vincristine